Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-003688
Filing Date
2020-04-29
Accepted
2020-04-29 17:38:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 31967
2 filename2.txt TEXT-EXTRACT 1217
  Complete submission text file 0000000000-20-003688.txt   45905
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filed for) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations